1,498 research outputs found
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
Get PDFPlerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells
Get PDF
Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
Get PDF
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies
Get PDFResolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib
Get PDFHLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment
Get PDF- …
